AI Article Synopsis

  • Corticobasal syndrome (CBS) involves various brain pathologies, including tau and occasionally alpha synuclein, affecting movement and behavior.
  • A 54-year-old man with CBS exhibited symptoms like poor response to levodopa and behavioral changes; he was later found to have advanced Lewy body disease after death.
  • Clinical signs such as mood disorders and autonomic issues may indicate Lewy body pathology in CBS patients, even when symptoms don't follow typical patterns.

Article Abstract

Corticobasal syndrome (CBS) is associated with diverse pathological substrates such as tau, prion protein, transactive response and, rarely, alpha synuclein. We report the case of a54-year-old man, who presented with asymmetric levodopa-poor-responsive parkinsonism, frontal lobe signs and behavioral changes. He was diagnosed with CBS, and postmortem analyses revealed Lewy body disease Braak stage VI without comorbid pathologies. Retrospectively, the clinical course of our patient and previous reports indicate that CBS plus mood changes and autonomic dysfunction, including reduced uptake of metaiodobenzylguanidine, are predictive factors of Lewy body pathology, even if the clinical picture is atypical.

Download full-text PDF

Source
http://dx.doi.org/10.1080/13554794.2021.1921220DOI Listing

Publication Analysis

Top Keywords

lewy body
12
corticobasal syndrome
8
body disease
8
autopsy case
4
case corticobasal
4
syndrome pure
4
pure diffuse
4
diffuse lewy
4
disease corticobasal
4
syndrome cbs
4

Similar Publications

Background: The neuropathologies of Alzheimer's disease (AD) and Lewy body disease (LBD) commonly co-occur. Parkinsonism is the hallmark feature in LBD but it can be difficult to predict the presence of these co-pathologies early in the course of clinical disease. Timely diagnosis has crucial implications, especially with the advent of disease-modifying therapies.

View Article and Find Full Text PDF

Asymmetric dopaminergic degeneration of the striatum is a characteristic feature of Parkinson's disease, associated with right-left asymmetry in motor function. As such, studying asymmetry provides insights into progressive neurodegeneration between cerebral hemispheres. Given the impact of Lewy pathology on various neurotransmitter systems beyond the dopaminergic, it may be that other neuronal systems in the predominantly affected hemisphere are similarly affected.

View Article and Find Full Text PDF

Nanodiamond-mediated delivery of microRNA-7 for the neuroprotection of dopaminergic neurons.

Front Bioeng Biotechnol

January 2025

Development and Regeneration Key Lab of Sichuan Province, Department of Histology and Embryology, Department of Pathology, Chengdu Medical College, Chengdu, China.

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the gradual loss of dopaminergic neurons in the substantia nigra and the accumulation of α-synuclein aggregates known as Lewy bodies. MicroRNA-7 (miR-7) targets the gene , which encodes α-synuclein, reducing its expression and alleviating neuronal damage in PD. Regulating the post-transcriptional levels of α-synuclein through miR-7 effectively inhibits its production.

View Article and Find Full Text PDF

Background: Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss, Lewy body build-up, and motor dysfunction. One of the primary pathogenic mechanisms of PD development is autophagy dysfunction and nitric oxide-mediated neurotoxicity.

Purpose: The current study focuses on autophagy and nitric oxide (NO) signaling roles in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated PD mice and their protection by their modulators.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!